News tagged with allergan

Related topics: food and drug administration

Valeant pitches potential eye drug, research focus

Valeant Pharmaceuticals is drawing attention to a potential glaucoma treatment and its focus on product development, as the Canadian drugmaker continues to build its case to investors for a takeover of Botox-maker Allergan.

Sep 25, 2014
popularity not rated yet | comments 0

Valeant Pharma expects 3Q revenue to top forecasts

Shares of Valeant Pharmaceuticals International Inc. climbed Wednesday after the Canadian drugmaker said it expects market share gains in most of its businesses and that its third-quarter revenue will top forecasts.

Sep 24, 2014
popularity not rated yet | comments 0

Valeant planning hostile bid for Allergan

Valeant plans to take a buyout offer for Allergan directly to its shareholders this week, as the Botox maker continues to rebuff its proposals that have risen as high as $53 billion.

Jun 17, 2014
popularity not rated yet | comments 0

Valeant raises cash-stock offer for Allergan (Update)

Valeant Pharmaceuticals has pumped more cash into its bid for Botox maker Allergan, and it also defended its business model on Wednesday, a day after its reluctant acquisition target aired more concerns about ...

May 28, 2014
popularity not rated yet | comments 0

Valeant, Ackman make $45.6B Allergan bid

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

Apr 22, 2014
popularity not rated yet | comments 0

Allergan

Allergan, Inc., is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products.

This text uses material from Wikipedia licensed under CC BY-SA